Abstract Interleukin-33 (IL-33) is a member of the IL-1 family and plays an ambivalent role in
autoimmune diseases. IL-33 signals via the ST2 receptor and drives cytokine production in …

Alarmins are endogenous, constitutively expressed, chemotacting and immune activating
proteins or peptides released because of non-programmed cell death (ie infections, trauma …

Chronic obstructive pulmonary disease (COPD) is an inflammatory lung disease
characterized by inflammatory cell activation and the release of inflammatory mediators …

Summary Interleukin‐33 (IL‐33) is a member of the IL‐1 cytokine family. It predominantly
induces type 2 immune responses and thus is protective against atherosclerosis and …

Objective: Interleukin-33 is an IL-1 family cytokine which signals via its T1/ST2 receptor, and
acts as a key regulator of inflammation, notably the type-2 response implicated in asthma …

Abstract Interleukin (IL)-33 is a cytokine that is released from epithelial and endothelial cells
at barrier surfaces upon tissue stress or damage to operate as an alarmin. IL-33 has been …

Autoimmune diseases (ADs), which are common immune-mediated inflammatory
syndromes, are characterized by an imbalance between T effector (Th) 1/Th17 cells and T …

Since the discovery of interleukin 33 as the adopted ligand for the then orphan ST2 receptor,
many studies have implicated this cytokine in the pathogenesis of respiratory allergy and …

This review focuses on the recent research on the epidemiology, outcome measures,
immunopathogenesis, genetics, clinical manifestations and management of Behçet's …

Behçet's disease (BD) is a chronic inflammatory disease. Increased productions of cytokines
including interleukin (IL)-1β and IL-18 are documented, and IL-1α and β gene …